Viela Bio, Inc. Common Stock
VIE
VIE was delisted on the 12th of March, 2021.
0 hedge funds and large institutions have $0 invested in Viela Bio, Inc. Common Stock in 2021 Q1 according to their latest regulatory filings, with 0 funds opening new positions, 0 increasing their positions, 0 reducing their positions, and 65 closing their positions.
100% less funds holding
Funds holding: 65 → 0 (-65)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
100% less capital invested
Capital invested by funds: $962M → $0 (-$962M)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 65
Top Buyers
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
-$290M |
| 2 |
Temasek Holdings
Singapore
|
-$146M |
| 3 |
HA
HHLR Advisors
Grand Cayman,
Cayman Islands
|
-$85.7M |
| 4 |
Vanguard Group
Malvern,
Pennsylvania
|
-$72.4M |
| 5 |
BlackRock
New York
|
-$65.4M |
VIE Hedge Fund Activity: Q1 2021 in Review
0 of the 5,696 institutional investors tracked by Wall St. Rank reported a position in Viela Bio, Inc. Common Stock (VIE) for Q1 2021, worth a combined $0 — down 100% from $962M a quarter earlier.
Sellers outnumbered buyers: 65 funds closed out of VIE and 0 opened new positions — a net loss of 65 holders — while 0 trimmed existing stakes and 0 added.
The largest seller was Fidelity Investments, exiting entirely with an estimated $290M sold.
- 0 institutional investors held Viela Bio, Inc. Common Stock (VIE) as of Q1 2021, down from 65 in Q4 2020.
- Funds reported $0 of Viela Bio, Inc. Common Stock stock for Q1 2021, down 100% quarter-over-quarter.
- 0 funds opened new Viela Bio, Inc. Common Stock positions in Q1 2021 and 65 closed out, a net change of -65 holders.
- The largest Viela Bio, Inc. Common Stock seller in Q1 2021 was Fidelity Investments, an estimated $290M sold.
Based on aggregated 13F filings for Q1 2021.